Author

Elizabeth S. Malsin

Northwestern UniversityORCID 0000-0002-3294-6752Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Approach:experimental assay· 1 Assay:flow cytometry· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

Alexander V. MishariniD· 2 shared Ankit BharatiD· 2 shared Cara J. GottardiiD· 2 shared Emmy JonassoniD· 2 shared Estefani DiaziD· 2 shared G. R. Scott BudingeriD· 2 shared Hiam Abdala‐ValenciaiD· 2 shared Jane E. DematteiD· 2 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Alexander V. MisharinORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Profibrotic monocyte-derived alveolar macrophages as a biomarker and therapeutic target in systemic sclerosis-associated interstitial lung disease

Nikolay S. Markov, Anthony Joseph Esposito, Karolina J. Senkow, Maxwell J. Schleck, Luisa Cusick, Zhan Yu, Yuliana V. Sokolenko, Estefani Diaz, Emmy Jonasson, Suchitra Swaminathan, Ziyan Lu, Radmila A. Nafikova, Samuel W. Fenske, Elsie G. Bunyan, Xóchitl G. Pérez-Leonor, , Monique Hinchcliff

The paper identifies profibrotic monocyte-derived alveolar macrophages as a biomarker and therapeutic target in SSc-ILD by analyzing BAL fluid and lung explants.

bioRxiv · Aug 7, 2025 · PreprintImmunology

A distinctive evolution of alveolar T cell responses is associated with clinical outcomes in unvaccinated patients with SARS-CoV-2 pneumonia

Nikolay S. Markov, Ziyou Ren, Karolina J. Senkow, Rogan A. Grant, Catherine A. Gao, Elizabeth S. Malsin, Lango Sichizya, Hermon G. Kihshen, Kathryn A. Helmin, Milica Jovisic, Jason M Arnold, Xóchitl G. Pérez-Leonor, Hiam Abdala‐Valencia, Suchitra Swaminathan, Julu Nwaezeapu, , Karen M. Ridge

The paper examines alveolar T cell responses in SARS-CoV-2 pneumonia patients, finding that early interferon signaling and targeting of structural proteins correlate with better clinical outcomes.

Nature Immunology · Aug 13, 2024Peer-reviewedSystems Biology